One of the Cities Hit Hardest by COVID-19 Reported No New Deaths - COVID-19 Clinical Trial
Breaking News | COVID-19

One of the Cities Hit Hardest by COVID-19 Reported No New Deaths

The City of Detroit reported no new deaths linked to COVID-19 on Sunday — the first time that has happened since the pandemic reached the city two months ago.Detroit — which has more than 20% of Michigan’s coronavirus deaths and cases — has been on a steady decline of day-to-day coronavirus cases and deaths due to several reasons.

The city is also aggressively testing its senior apartment buildings, the latest strategy that started with testing at nursing homes and long-term care facilities in the city.In all, there are 10,373 cases of coronavirus and 1,257 deaths in Detroit. In the state, there are 4,891 deaths from coronavirus and 51,142 cases. The number of deaths reported Sunday were among the lowest since the pandemic began.

Global Push for Inquiry Into Covid-19 Response

Monday’s virtual meeting brings together envoys from 194 member states of the World Health Organization (WHO).The WHO will face questions on how it dealt with the coronavirus pandemic.Chinese President Xi Jinping, who has defended his country’s actions during the outbreak, is to speak during Monday’s opening ceremony.

China’s foreign ministry earlier repeated Beijing’s opposition to an investigation into the origin and spread of the virus, saying it was premature while the pandemic was still unfolding. The two-day assembly – an annual meeting that reviews the work of the UN’s health agency – comes amid recriminations between the US and China over the virus.

Moderna Reports Positive Data on Early-Stage Coronavirus Vaccine Trial

Moderna‘s closely watched early-stage human trial for a coronavirus vaccine produced Covid-19 antibodies in all 45 participants, the biotech company announced Monday, sending the company’s shares surging 30% in premarket trading.Each participant received a 25, 100 or 250 microgram dose, with 15 people in each dose group. Participants received two doses of the potential vaccine via intramuscular injection in the upper arm approximately 28 days apart.

At day 43, or two weeks following the second dose, levels of binding antibodies in the 25 microgram group were at the levels generally seen in blood samples from people who recovered from the disease, the company said. Those in the 100 microgram had antibodies that “significantly exceeded levels” in recovered patients. Data on a second dose was not available for the 250 microgram group, the company said.

Share this:

Your choice regarding cookies on this site

We use cookies to optimize site functionality and give you the best experience. Necessary cookies enable core functionality. The website cannot function properly without these cookies and can only be disabled by changing your browser preferences.

For more detailed information on the cookies we use, please check our Privacy Policy.

By continuing to access this website you are giving us consent to collect cookies.

Want to stay informed?

With an ever-changing situation like COVID-19, it’s important to stay as tuned in as possible. Submit your information below so we can send you periodic updates.